This product theater will teach participants the role of CGM and its clinical benefit for patients, as well as real-time insulin dosing methods and the difference of therapeutic CGM. Featured speakers include Jake Leach, Keri Leone, MS, RD, CDE and Davida Kruger, MSN APN-BC, BC-ADM.
|2:45 PM||Doors Open and Refreshments Served|
|2:45 PM||Hands-on Demonstrations of Dexcom G6® CGM System||Demonstration Booths|
|2:55 PM||Welcome and Introduction||Keri Leone, MS, RD, CDE|
|3:00 PM||Empowering Patient Choice with Interoperability: The Dexcom Ecosystem and Emerging Dexcom Technologies||Jake Leach|
|3:20 PM||Controversies in Glucose Metrics: A1C Out and Time in Range In?||Davida Kruger, MSN APN-BC, BC-ADM|
|3:40 PM||Questions and Answers||All|
First and only single-use, professional CGM system with blinded or unblinded mode
Dexcom, Inc. (NASDAQ:DXCM) announced today the U.S. Food and Drug Administration (FDA) has cleared the Dexcom G6 Pro Continuous Glucose Monitoring (CGM)...
Join Dexcom at the upcoming AADE conference from August 9-12, 2019, in Houston, TX. Attendees are invited to attend a special Dexcom product theater and participate in the Dexcom DANA Technology Workshop (details for both...
The ATDC conference will be held on July 11-14, 2019 in Keystone, CO. This event will focus on using new technologies to overcome challenges in day-to-day management of diabetes. Clinical studies and the benefits of Dexcom...